Since the previous disclosure, the number of issued stock acquisition rights issued is 3,026,000 shares, with an exercise ratio of 30.26%; unexercised rights total 50,700 units (5,070,000 shares) remaining, a reduction from 80,960 units (8,096,000 shares) at the previous disclosure. As of September 9, with exercises on September 2 and the most recent exercise, 21,000 shares worth of stock acquisition rights have been exercised, representing a clearly over-exercise exceeding 10% of the total listed shares as of the payment date August 7.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4598","jir_company_name":"Delta-Fly Pharma Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4598-20260909-01.pdf","jir_short_summary":"Since the previous disclosure, the number of issued stock acquisition rights issued is 3,026,000 shares, with an exercise ratio of 30.26%; unexercised rights total 50,700 units (5,070,000 shares) remaining, a reduction from 80,960 units (8,096,000 shares) at the previous disclosure. As of September 9, with exercises on September 2 and the most recent exercise, 21,000 shares worth of stock acquisition rights have been exercised, representing a clearly over-exercise exceeding 10% of the total listed shares as of the payment date August 7.","jir_summary":"### Section Heading\nThis is a progress report on the large-scale exercise of the 12th stock acquisition rights issued through a third-party allotment. Of the total issued 100,000 units, the number of delivered shares to date is equivalent to 3,026,000 shares, with an exercise ratio of 30.26%, a high level. Unexercised shares have decreased to 5,070,000 shares, showing a notable impact on the total issued shares.\n\n### Section 2 Heading\nSince the last disclosure, the exercise status includes 791,000 shares on September 2 and 2,100,000 shares on September 9, with a total of 21,000 shares actually exercised. This large exercise exceeds 10% of the listed shares as of the payment date August 7, and is described as not subject to restrictions under listing rules. Ongoing monitoring is required for potential dilution effects and shareholder value.","jir_financial_highlights":"Number of delivered shares (exercised stock acquisition rights): 3,026,000 shares ( Delivery since the previous disclosure)\nExercise ratio against total issued shares: 30.26\uff05 ( Exercise ratio since the previous disclosure)\nUnexercised stock acquisition rights: 50,700 units (5,070,000 shares) (As of previous disclosure: 80,960 units (8,096,000 shares) \u2192 decrease)\nShares delivered by exercise date: 791,000 shares (as of September 2)\nMaximum exercised shares (as of September 9): 21,000 shares (as of September 9)","jir_category":"","jir_hashtags":"#Delta-Fly_Pharma, #StockAcquisitionRight, #LargeScaleExercise, #ListedShares","jir_key_figures":"Delivered shares: 3,026,000 shares\nUnexercised stock acquisition rights: 50,700 units (5,070,000 shares)\nExercise ratio: 30.26%","jir_meta_title":"[Delta-Fly Pharma] Notice of Large-Scale Exercise of the 12th Stock Acquisition Rights Issued Through Third-Party Allotment","jir_meta_description":"Delta-Fly Pharma discloses large-scale exercise of the 12th stock acquisition rights. Delivered shares total 3,026,000 shares; unexercised rights decrease to 5,070,000 shares. Exercise ratio 30.26%; detailed exercise dates up to September 9 are provided.","jir_og_title":"Delta-Fly Pharma Notice of Large-Scale Exercise of the 12th Stock Acquisition Rights","jir_og_description":"Delta-Fly Pharma discloses large-scale exercise of the 12th stock acquisition rights. Delivered shares total 3,026,000 shares; unexercised rights decrease to 5,070,000 shares. Detailed exercise status up to September 9 is reported.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59921,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-111855","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n